Clinical trial

Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab

NCT00737763

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2008-10-01

PhasePHASE2

Study timeline

Study start (unknown)2008-10-01Date precision: month

Registry last updated2014-05-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

efalizumabDRUG

placeboDRUG

Sponsors & collaborators

Emory Universitylead sponsor

Juvenile Diabetes Research Foundationcollaborator

Genentech, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00737763 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.